CN102875274B - Polyfluorinated aromatic ether compounds and synthesis method and application thereof - Google Patents
Polyfluorinated aromatic ether compounds and synthesis method and application thereof Download PDFInfo
- Publication number
- CN102875274B CN102875274B CN201210390666.3A CN201210390666A CN102875274B CN 102875274 B CN102875274 B CN 102875274B CN 201210390666 A CN201210390666 A CN 201210390666A CN 102875274 B CN102875274 B CN 102875274B
- Authority
- CN
- China
- Prior art keywords
- cdcl
- nmr
- mhz
- liquid crystal
- ether compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- ZLEWCCVSOGMCQR-UHFFFAOYSA-N CC(C)(C)c(cc1)ccc1Oc(c(F)c(cc1F)F)c1F Chemical compound CC(C)(C)c(cc1)ccc1Oc(c(F)c(cc1F)F)c1F ZLEWCCVSOGMCQR-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention discloses polyfluorinated aromatic ether compounds and a synthesis method and application thereof. In organic solvent, substituted phenol, penta fluoro benzene, inorganic base and oxidant react at the reaction temperature of 120 DEG C under the action of a palladium catalyst to form the polyfluorinated aromatic ether compounds. The polyfluorinated aromatic ether compounds are efficiently and selectively synthesized through catalysis of palladium; the compounds have wide application in the aspect of preparation of thin film transistor-liquid crystal display (TFT-LCD) liquid crystal materials; and the synthesis route has the advantages of high reaction yield and short reaction time.
Description
Technical field
The invention belongs to synthetic chemistry field, be specifically related to a kind of polyfluoro aromatic oxide compounds and synthetic method and application.
Background technology
The research work of China's liquid crystal material starts from 1969, but owing to being subject to domestic LCD industry overall technology, the restriction of equipment level and infusion of financial resources, liquid crystal material is never put into national key scientific and technological project, the development of reasearch funds and manpower shortage restriction the sector, until China in 1987 just formally produces liquid crystal material, broken the long-term technical monopoly of Japan and Germany, but except obtaining some breakthroughs perfluor benzyne class liquid crystal material synthetic aspect in organic place, Shanghai, very slow in TFT-LCD liquid crystal material research and development progress especially with abroad there is a big difference aspect the new development and application that obtains liquid crystal material.For TFT-LCD, with liquid crystal material, generally to possess good chemical stability, wider operating temperature range, low-viscosity and high electric charge conservation rate.Wherein fluoro liquid crystals is due to comparatively approaching on fluorine atom and hydrogen atom volume, therefore structurally can not affect because of the steric hindrance of group the ordered arrangement of liquid crystal, fluorine atom has higher electronegativity simultaneously, can guarantee that fluorinated liquid crystal structurally has suitable moment of dipole, and fluorinated liquid crystal viscosity is lower, show that speed of response is fast, resistance conservation rate is high and become the quality matetrial of the high-grade liquid crystal of development TFT-LCD class.Therefore research and develop polyfluoro class liquid crystalline cpd and become the synthetic main flow of current liquid crystal material, in polyfluoro class liquid crystalline cpd synthetic, the effectively synthetic of polyfluoro aromatic compound is committed step, based on the importance of this compounds, invention is a kind of efficient, and the novel method that low cost is prepared polyfluoro aromatic compound is very necessary.
Summary of the invention
The object of the present invention is to provide a kind of polyfluoro aromatic oxide compounds and synthetic method and application, the present invention be a kind of by palladium catalysis efficient selective synthesize polyfluoro aromatic oxide compounds, this compounds is having been widely used aspect preparation TFT-LCD liquid crystal material, it is high that synthetic route of the present invention has reaction yield, the advantage that the reaction times is short.
For achieving the above object, the present invention adopts following technical scheme:
A method for synthetic polyfluoro aromatic oxide compounds, is in organic solvent, makes fortified phenol, penta fluoro benzene, mineral alkali and oxygenant, and under palladium catalyst effect, temperature of reaction is 120 ℃, generates polyfluoro aromatic oxide compounds.Reaction formula is:
The mol ratio of described fortified phenol, penta fluoro benzene, palladium catalyst, mineral alkali and oxygenant is 2:1:0.1:2:2.
Described palladium catalyst is Pd (OAc)
2.
Described oxygenant is AgNO
3.
Described mineral alkali is K
2cO
3.
Described organic solvent is DMF.
The synthetic polyfluoro aromatic oxide compounds of a kind of method as above is for the preparation of liquid crystal material.
Beneficial effect of the present invention: the present invention be a kind of by palladium catalysis efficient selective synthesize polyfluoro aromatic oxide compounds, this compounds is having been widely used aspect preparation TFT-LCD liquid crystal material, it is high that synthetic route of the present invention has reaction yield, the advantage that the reaction times is short.
Embodiment
Using DMF (2ml) as solvent, add phenol (0.20 mmol), K
2cO
3(0.20 mmol) reacts 30min, then adds penta fluoro benzene (0.10 mmol and AgNO
3(0.20 mmol), at Pd (OAc)
2(0.010 mmol) katalysis, heating 120
oc reacts 12h.Except after desolventizing, column chromatography obtains corresponding polyfluoro aromatic oxide.
Productive rate 91%.
1h NMR (400 MHz, CDCl
3)
δ7.27 – 7.18 (m, 2H), 7.06 – 6.97 (m, 1H), 6.90 – 6.78 (m, 3H).
13c NMR (101 MHz, CDCl
3)
δ156.0 (s), 146.7 – 146.4 (m), 144.2 – 143.9 (m), 141.8 – 141.5 (m), 139.3 – 139.0 (m), 133.2 – 133.0 (m), 128.6 (s), 122.6 (s), 114.3 (s), 100.6 (t
j=22.9 Hz).
19f NMR (376 MHz, CDCl
3)
δ-138.7 –-138.9 (m, 2F) ,-154.0 –-154.1 (m, 2F) .GC-MS
m/z242 (M
+). HRMS (EI): calcd. for C
12h
6f
4o 242.0355; Found 242.0357. IR (KBr) n 1641,1591,1521,1485,1202,1067,947,839,811,754,687 cm
1.
Productive rate 87%.
1h NMR (400 MHz, CDCl
3)
δ7.04 (d,
j=7.6 Hz, 2H), 6.94 – 6.82 (m, 1H), 6.79 (d,
j=7.6 Hz, 2H), 2.24 (s, 3H).
13c NMR (101 MHz, CDCl
3)
δ155.2 (s), 147.8 – 147.5 (m), 145.3 – 145.0 (m), 142.9 – 142.7 (m), 140.4 – 140.2 (m), 133.3 (s), 130.2 (s), 115.4 (s), 101.6 (t
j=22.9 Hz), 20.56 (s).
19f NMR (376 MHz, CDCl
3)
δ-138.8 –-139.0 (m, 2F) ,-154.3 –-154.2 (m, 2F). GC-MS
m/z256 (M
+). HRMS (EI): calcd. for C
13h
8f
4o 256.0511; Found 256.0510. IR (KBr) n 3084,2926,1641,1591,1521,1485,1203,1172,1067,947,755 cm
1.
Productive rate 85%.
1h NMR (400 MHz, CDCl
3)
δ7.33 (d,
j=7.4 Hz, 1H), 7.18 (t,
j=7.8 Hz, 1H), 7.11 (t,
j=7.3 Hz, 1H), 7.05 – 6.93 (m, 1H), 6.72 (d,
j=8.0 Hz, 1H), 2.52 (s, 3H).
13c NMR (101 MHz, CDCl
3)
δ155.6 (s), 147.9 – 147.6 (m), 145.4 – 145.2 (m), 142.9 – 142.7 (m), 140.4 – 140.2 (m), 135.1 – 134.7 (m), 131.5 (s), 127.3 (s), 127.0 (s), 123.7 (s), 113.56 (s), 101.48 (t
j=23.0 Hz), 15.87 (s).
19f NMR (376 MHz, CDCl
3)
δ-138.9 –-139.1 (m, 2F) ,-154.3 –-154.2 (m, 2F). GC-MS
m/z256 (M
+). HRMS (EI): calcd. for C
13h
8f
4o 256.0511; Found 256.0510. IR (KBr) n 3084,2931,1642,1588,1519,1483,1224,1176,1118,1067,945,750 cm
1.
Productive rate 85%.
1h NMR (400 MHz, CDCl
3)
δ7.39 (d,
j=7.8 Hz, 2H), 7.05 – 6.95 (m, 1H), 6.93 (d,
j=7.8 Hz, 2H), 1.36 (s, 9H).
13c NMR (101 MHz, CDCl
3)
δ155.0 (s), 147.8 – 147.6 (m), 146.7 (s), 145.4 – 145.1 (m), 143.0 – 142.8 (m), 140.5 – 140.3 (m), 134.8 – 134.3 (m), 126.6 (s), 115.0 (s), 101.7 (t
j=22.9 Hz), 34.29 (s), 31.40 (s).
19f NMR (376 MHz, CDCl
3)
δ-138.86 –-139.02 (m, 2F) ,-154.08 (dt,
j=17.8,8.6 Hz, 2F). GC-MS
m/z298 (M
+). HRMS (EI): calcd. for C
16h
14f
4o 298.0981; Found 298.0985. IR (KBr) n 3085,2966,1641,1606,1517,1483,1221,1175,1067,944,831,716,546 cm
1.
Productive rate 82%.
1h NMR (400 MHz, CDCl
3)
δ7.47 (d,
j=7.5 Hz, 1H), 7.18 – 7.10 (m, 2H), 7.06 – 6.93 (m, 1H), 6.65 (d,
j=7.9 Hz, 1H), 1.55 (s, 9H).
13c NMR (101 MHz, CDCl
3)
δ156.0 (s), 148.0 – 147.7 (m), 145.5 – 145.2 (m), 142.7 – 142.6 (m), 140.3 – 140.1 (m), 138.3 (s), 134.1 – 133.9 (m), 127.5 (s), 127.1 (s), 123.5 (s), 113.8 (s), 101.4 (t
j=23.0 Hz), 34.95 (s), 29.85 (s).
19f NMR (376 MHz, CDCl
3)
δ-138.78 –-138.94 (m, 2F) ,-153.96 (dt,
j=21.3,8.7 Hz, 2F). GC-MS
m/z298 (M
+). HRMS (EI): calcd. for C
16h
14f
4o 298.0981; Found 298.0987. IR (KBr) n 3084,2963,2873,1642,1520,1482,1364,1189,945,809,749,482 cm
1.
Productive rate 90%.
1h NMR (400 MHz, CDCl
3)
δ7.73 – 7.70 (m, 2H), 7.55 – 7.51 (m, 3H), 7.47 – 7.43 (m, 1H), 7.38 – 7.27 (m, 2H), 7.00 – 6.89 (m, 2H).
13c NMR (101 MHz, CDCl
3)
δ154.0 (s), 147.9 – 147.6 (m), 145.4 – 145.1 (m), 142.7 – 142.5 (m), 140.2 – 140.0 (m), 137.4 (s), 134.8 – 134.5 (m), 131.7 (s), 131.5 (s), 129.5 (s), 128.7 (s), 128.3 (s), 127.6 (s), 124.2 (s), 114.6 (s), 101.49 (t
j=23.0 Hz).
19f NMR (376 MHz, CDCl
3)
δ-138.87 (dt,
j=19.8,9.7 Hz, 2F) ,-154.05 –-154.30 (m, 2F). GC-MS
m/z318 (M
+). HRMS (EI): calcd. for C
18h
10f
4o 318.0668; Found 318.0666. IR (KBr) n 3078,1642,1520,1483,1258,1195,1119,1064,946,722 cm
1.
Productive rate 93%.
1h NMR (400 MHz, CDCl
3)
δ7.05 – 6.97 (m, 1H), 6.88 – 6.86 (m, 1H), 6.74 – 6.72 (m, 2H), 2.41 – 2.40 (m, 6H).
13c NMR (101 MHz, CDCl
3)
δ157.3 (s), 155.7 (s), 147.9 – 147.6 (m), 145.5 – 145.2 (m), 143.1 – 142.9 (m), 140.6 – 140.4 (m), 139.9 (s), 125.6 (s), 113.2 (s), 101.7 (t
j=23.0 Hz), 21.18 (s).
19f NMR (376 MHz, CDCl
3)
δ-138.86 –-139.25 (m, 2F) ,-154.14 –-154.43 (m, 2F). GC-MS
m/z270 (M
+). HRMS (EI): calcd. for C
14h
10f
4o 270.0668; Found 270.0667. IR (KBr) n 3082,2924,1642,1619,1592,1486,1290,1143,1079,946,834,716,682 cm
1.
Productive rate 83%.
1h NMR (400 MHz, CDCl
3)
δ7.04 – 6.92 (m, 3H), 6.52 (d,
j=8.0 Hz, 1H), 2.37 (s, 6H).
13c NMR (101 MHz, CDCl
3)
δ155.5 (s), 147.8 – 147.6 (m), 145.4 – 145.1 (m), 142.8 – 142.6 (m), 140.4 – 140.2 (m), 139.0 (s), 135.2 (s), 125.9 (s), 125.8 (s), 125.2 (d
j=1.8 Hz), 111.2 (s), 101.3 (t,
j=23.0 Hz), 20.0 (s), 11.8 (s).
19f NMR (376 MHz, CDCl
3)
δ-138.99 –-139.21 (m, 2F) ,-154.77 –-154.98 (m, 2F). GC-MS
m/z270 (M
+). HRMS (EI): calcd. for C
14h
10f
4o 270.0668; Found 270.0664. IR (KBr) n 3092,2919,2851,1643,1581,1189,1126,941,847,765,717 cm
1.
Productive rate 85%.
1h NMR (400 MHz, CDCl
3)
δ7.14 (d,
j=7.4 Hz, 1H), 7.03 – 6.91 (m, 1H), 6.86 (d,
j=7.4 Hz, 1H), 6.44 (s, 1H), 2.39 (s, 3H), 2.26 (s, 3H).
13c NMR (101 MHz, CDCl
3)
δ155.4 (s), 147.8 – 147.5 (m), 145.4 – 145.1 (m), 142.8 – 142.6 (m), 140.4 – 140.2 (m), 137.0 (s), 131.2 (s), 124.2 (d
j=31.8 Hz), 114.3 (s), 101.4 (t,
j=23.0 Hz), 21.04 (s), 15.53 (s).
19f NMR (376 MHz, CDCl
3)
δ-138.92 –-139.15 (m, 2F) ,-154.17 –-154.37 (m, 2F). GC-MS
m/z270 (M
+). HRMS (EI): calcd. for C
14h
10f
4o 270.0668; Found 270.0667. IR (KBr) n 3096,2923,2857,1644,1515,1489,1243,1125,941,842,813,713 cm
1.
Productive rate 92%.
1h NMR (400 MHz, CDCl
3)
δ8.32 (dd,
j=6.3,2.8 Hz, 1H), 7.80 (dd,
j=6.1,2.9 Hz, 1H), 7.51 (dt,
j=7.5,7.0 Hz, 3H), 7.24 (t,
j=8.0 Hz, 1H), 6.93 (tt,
j=9.9,7.0 Hz, 1H), 6.59 (d,
j=7.7 Hz, 1H).
13c NMR (101 MHz, CDCl
3)
δ153.2 (s), 147.9 – 147.6 (m), 145.4 – 145.2 (m), 143.0 – 142.7 (m), 140.5 – 140.2 (m), 134.8 (s), 134.6 – 134.3 (m), 127.7 (s), 127.0 (s), 126.2 (s), 125.2 (s), 124.8 (s), 123.6 (s), 121.6 (s), 107.6 (s), 102.1 (t
j=22.9 Hz).
19f NMR (376 MHz, CDCl
3)
δ-138.69 –-138.86 (m, 2F) ,-153.98 –-154.17 (m, 2F). GC-MS
m/z292 (M
+). HRMS (EI): calcd. for C
16h
8f
4o 292.0511; Found 292.0507. IR (KBr) n 3093,1642,1599,1577,1513,1493,1231,1177,1104,938,788,766 cm
1.
Productive rate 94%.
1h NMR (400 MHz, CDCl
3)
δ7.26 (t,
j=8.3 Hz, 1H), 7.04 – 6.96 (m, 1H), 6.73 – 6.70 (m, 1H), 6.62 (t,
j=2.4 Hz, 1H), 6.59 – 6.56 (m, 1H), 3.83 (s, 3H).
13c NMR (101 MHz, CDCl
3)
δ161.0 (s), 158.2 (s), 147.8 – 147.5 (m), 145.3 – 145.0 (m), 142.9 – 142.7 (m), 140.4 – 140.2 (m), 134.3 – 134.0 (m), 130.2 (s), 109.1 (s), 107.5 (s), 102.3 (s), 102.0 (t
j=23.2 Hz), 55.3 (s).
19f NMR (376 MHz, CDCl
3)
δ-136.64 –-140.96 (m, 2F) ,-154.21 (ddd,
j=21.5,9.8,7.1 Hz, 2F). GC-MS
m/z292 (M
+). HRMS (EI): calcd. for C
13h
8f
4o
2272.0460; Found 272.0452. IR (KBr) n 3075,2976,1601,1529,1259,1147,1063,949,855,771 cm
1.
Productive rate 84%.
1h NMR (400 MHz, CDCl
3)
δ6.97 – 6.91 (m, 1H), 6.87 – 6.78 (m, 2H), 6.78 – 6.67 (m, 2H), 3.91 (q,
j=7.0 Hz, 2H), 1.18 (t,
j=7.0 Hz, 3H).
13c NMR (101 MHz, CDCl
3)
δ149.1 (s), 147.6 – 147.4 (m), 146.3 (s), 145.2-144.9 (m), 142.4 – 142.2 (m), 140.0 – 139.8 (m), 136.3 – 136.0 (m), 124.9 (s), 120.8 (s), 117.9 (s), 114.1 (s), 100.4 (t
j=23.0 Hz), 64.5 (s), 14.5 (s).
19f NMR (376 MHz, CDCl
3)
δ-139.97 –-140.09 (m, 2F) ,-155.22 –-155.36 (m, 2F). GC-MS
m/z286 (M
+). HRMS (EI): calcd. for C
14h
10f
4o
2286.0617; Found 286.0619. IR (KBr) n 3094,2982,1641,1605,1587,1320,1253,1122,1196,927,835,752 cm
1.
Productive rate 75%.
1h NMR (400 MHz, CDCl
3)
δ6.98 (t,
j=8.0 Hz, 1H), 6.92 – 6.79 (m, 1H), 6.33 (d,
j=7.9 Hz, 1H), 6.22 (s, 2H), 3.53 (s, 2H).
13c NMR (101 MHz, CDCl
3)
δ152.7 (s), 150.2,147.8 – 147.5 (m), 145.3 – 145.1 (m), 142.6 – 142.4 (m), 140.1 – 140.0 (m), 139.4 (s), 136.0 (s), 129.8 (s), 126.1 (s), 123.3 (s), 122.2 (s), 112.2 (s), 101.83 (t
j=22.9 Hz).
19f NMR (376 MHz, CDCl
3)
δ-138.83 –-139.06 (m, 2F) ,-154.15 (dt,
j=21.8,8.6 Hz, 2F). GC-MS
m/z257 (M
+). HRMS (EI): calcd. for C
12h
7f
4nO 257.0464; Found 257.0462. IR (KBr) n 3325,1642,1535,1487,1132,1259,1147,1063,949,855,775 cm
1.
Productive rate 63%.
1h NMR (400 MHz, CDCl
3)
δ8.05 (s, 1H), 7.40 – 7.33 (m, 2H), 6.90 – 6.83 (m, 1H), 6.80 (d,
j=9.0 Hz, 2H), 2.03 (s, 3H).
13c NMR (101 MHz, CDCl
3)
δ168.9 (s), 153.6 (s), 147.8 – 147.5 (m), 145.4 – 145.1 (m), 142.8 – 142.6 (m), 140.3 – 140.1 (m), 134.6 – 134.3 (m), 134.0 (s), 121.8 (s), 116.0 (s), 101.85 (t
j=22.9 Hz), 24.15 (s).
19f NMR (376 MHz, CDCl
3)
δ-138.61 –-138.84 (m, 2F) ,-154.27 (ddd,
j=21.5,9.7,7.1 Hz, 2F). GC-MS
m/z299 (M
+). HRMS (EI): calcd. for C
14h
9f
4nO
2299.0569; Found 299.0565. IR (KBr) n 3288,1660,1507,1487,1207,1177,1070,943,831,715 cm
1.
Productive rate 64%.
1h NMR (400 MHz, CDCl
3)
δ7.95 – 7.85 (m, 2H), 7.02 – 6.89 (m, 3H), 2.51 (s, 3H).
13c NMR (101 MHz, CDCl
3)
δ196.4 (s), 160.4 (s), 147.6 – 147.8 (m), 145.4 – 145.1 (m), 142.7 – 142.5 (m), 140.2 – 140.0 (m), 133.1 (s), 130.7 (s), 115.25 (s), 102.62 (t
j=22.9 Hz), 26.44 (s).
19f NMR (376 MHz, CDCl
3)
δ-137.94 –-138.09 (m, 2F) ,-153.66 (ddd,
j=21.5,10.0,7.1 Hz, 2F). GC-MS
m/z284 (M
+). HRMS (EI): calcd. for C
14h
8f
4o
2284.0460; Found 284.0458. IR (KBr) n 3045,1678,1644,1599,1504,1488,1268,1220,1166,938,847,716,590 cm
1.
Productive rate 85% yield.
1h NMR (400 MHz, CDCl
3)
δ8.04 (d,
j=8.1 Hz, 1H), 7.81 (s, 1H), 7.57 (t,
j=8.0 Hz, 1H), 7.38 (d,
j=8.3 Hz, 1H), 7.17 – 7.02 (m, 1H).
13c NMR (101 MHz, CDCl
3)
δ157.3 (s), 149.3 (s), 147.9 – 147.7 (m), 145.4 – 145.2 (m), 142.6 – 142.4 (m), 140.1 – 139.9 (m), 133.2 – 133.0 (m), 130.7 (s), 121.9 (s), 118.8 (s), 110.7 (s), 103.1 (t
j=22.9 Hz).
19f NMR (376 MHz, CDCl
3)
δ-130.78 –-142.50 (m, 2F) ,-154.15 (dt,
j=21.8,8.6 Hz, 2F). GC-MS
m/z287 (M
+). HRMS (EI): calcd. for C
12h
5f
4nO
3287.0206; Found 287.0205. IR (KBr) n 1642,1532,1438,1351,1220,1173,958,755,715 cm
1.
Productive rate 57%.
1h NMR (400 MHz, CDCl
3)
δ7.09 – 6.94 (m, 5H).
13c NMR (101 MHz, CDCl
3)
δ160.2 (s), 157.8 (s), 153.2 (s), 147.9 – 147.6 (m), 145.4 – 145.1 (m), 142.8 – 142.6 (m), 140.3 – 140.1 (m), 134.7 – 134.4 (m), 117.1 (d
j=8.3 Hz), 116.4 (s), 116.2 (s), 101.9 (t,
j=22.9 Hz).
19f NMR (376 MHz, CDCl
3)
δ-119.53 –-119.72 (m, 1F) ,-138.47 –-138.63 (m, 2F) ,-154.19 –-154.32 (m, 2F). GC-MS
m/z260 (M
+). HRMS (EI): calcd. for C
12h
5f
5o 260.0261; Found 260.0259. IR (KBr) n 3088,1642,1502,1485,1274,1190,1068,945,832,736,513 cm
1.
Productive rate 80%.
1h NMR (400 MHz, CDCl
3)
δ7.38 – 7.23 (m, 2H), 7.09 – 6.85 (m, 3H).
13c NMR (101 MHz, CDCl
3)
δ155.68 (s), 147.72 (td,
j=12.0,4.3 Hz), 145.24 (td,
j=12.0,4.2 Hz), 142.68 (ddd,
j=14.7,4.9,2.3 Hz), 140.18 (ddd,
j=15.0,4.8,2.3 Hz), 134.04 (tt,
j=13.1,3.9 Hz), 129.77 (s), 128.99 (s), 116.96 (s), 102.19 (t,
j=22.9 Hz).
19f NMR (376 MHz, CDCl
3)
δ-138.38 (qt,
j=11.7,1.8 Hz, 2F) ,-154.03 (ddd,
j=21.5,9.9,7.0 Hz, 2F). GC-MS
m/z275 (M
+) .IR (KBr) n 3086,1642,1588,1521,1485,1210,1177,1066,949,827,716,502 cm
1.
Productive rate 78%.
1h NMR (400 MHz, CDCl
3)
δ9.02 (s, 1H), 8.23 (d,
j=8.3 Hz, 1H), 7.62 (d,
j=8.1 Hz, 1H), 7.58 – 7.48 (m, 1H), 7.44 (t,
j=7.9 Hz, 1H), 7.09 – 6.92 (m, 2H).
13c NMR (101 MHz, CDCl
3)
δ152.7 (s), 150.2 (s), 147.8 – 147.6 (m), 145.4 – 145.1 (m), 142.7 – 142.4 (m), 140.2 – 140.0 (m), 139.4 (s), 136.0 (s), 135.1 – 134.6 (m), 129.8 (s), 126.1 (s), 123.3 (s), 122.2 (s), 112.2 (s), 101.8 (t
j=22.9 Hz).
19f NMR (376 MHz, CDCl
3)
δ-138.64 –-138.87 (m, 2F) ,-153.84 (dt,
j=21.1,8.6 Hz, 2F). GC-MS
m/z293 (M
+). HRMS (EI): calcd. for C
15h
7f
4nO 293.0464; Found 293.0461. IR (KBr) n 3046,1643,1500,1486,1470,1315,1246,1186,1104,943,822,789,789,719 cm
1.
The foregoing is only preferred embodiment of the present invention, all equalizations of doing according to the present patent application the scope of the claims change and modify, and all should belong to covering scope of the present invention.
Claims (4)
1. a method for synthetic polyfluoro aromatic oxide compounds, is characterized in that: in organic solvent, make fortified phenol, penta fluoro benzene, mineral alkali and oxygenant, under palladium catalyst effect, temperature of reaction is 120 ℃, generates polyfluoro aromatic oxide compounds;
Reaction formula is:
Wherein said R is H, Cl, NO
2, NH
2, OCH
3, OC
2h
5, Ph, F, CH
3cO, CH
3cONH, CH
3, (CH
3)
3c;
Described palladium catalyst is Pd (OAc)
2;
Described oxygenant is AgNO
3.
2. the method for synthetic polyfluoro aromatic oxide compounds according to claim 1, is characterized in that: the mol ratio of described fortified phenol, penta fluoro benzene, palladium catalyst, mineral alkali and oxygenant is 2:1:0.1:2:2.
3. the method for synthetic polyfluoro aromatic oxide compounds according to claim 1, is characterized in that: described mineral alkali is K
2cO
3.
4. the method for synthetic polyfluoro aromatic oxide compounds according to claim 1, is characterized in that: described organic solvent is DMF.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210390666.3A CN102875274B (en) | 2012-10-16 | 2012-10-16 | Polyfluorinated aromatic ether compounds and synthesis method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210390666.3A CN102875274B (en) | 2012-10-16 | 2012-10-16 | Polyfluorinated aromatic ether compounds and synthesis method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102875274A CN102875274A (en) | 2013-01-16 |
CN102875274B true CN102875274B (en) | 2014-05-07 |
Family
ID=47476836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210390666.3A Expired - Fee Related CN102875274B (en) | 2012-10-16 | 2012-10-16 | Polyfluorinated aromatic ether compounds and synthesis method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102875274B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104086377A (en) * | 2014-07-07 | 2014-10-08 | 太仓博亿化工有限公司 | Synthesis method of polymethoxy substituted diphenyl ether compound |
CN111925325B (en) * | 2020-02-17 | 2021-12-17 | 浙江大学 | Synthetic method of diaryl ether compound |
-
2012
- 2012-10-16 CN CN201210390666.3A patent/CN102875274B/en not_active Expired - Fee Related
Non-Patent Citations (4)
Title |
---|
Aromatic Polyfluoro-compounds. Part L1V.l Copper-assisted Nucleophilic;J. Burdon et al.;《J.C.S》;19721231;763-769 * |
Highly fluorinated biphenyl ether systems as dopants for fast-response liquid crystal display applications;Matthew R. Cargill et al.;《Liquid Crystals》;20111231;第38卷(第8期);1069-1078 * |
J. Burdon et al..Aromatic Polyfluoro-compounds. Part L1V.l Copper-assisted Nucleophilic.《J.C.S》.1972,763-769. |
Matthew R. Cargill et al..Highly fluorinated biphenyl ether systems as dopants for fast-response liquid crystal display applications.《Liquid Crystals》.2011,第38卷(第8期),1069-1078. |
Also Published As
Publication number | Publication date |
---|---|
CN102875274A (en) | 2013-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103254903A (en) | Liquid crystal compound containing difluoro-methylene key bridge, preparation method thereof and composition containing liquid crystal compound | |
CN103194242A (en) | Liquid crystal compound containing deuterium and preparation method as well as application thereof | |
CN103773386B (en) | Liquid crystal compound containing 1,4-dioxane and pentafluoro-allyloxy structure and liquid crystal composition thereof | |
CN102875274B (en) | Polyfluorinated aromatic ether compounds and synthesis method and application thereof | |
CN101787042A (en) | Copper-nitrogen compound and application thereof | |
CN102153579B (en) | Method for synthesizing N-tert-butoxycarbonyl-1,2,5,6-tetrahydropyridine-4-boronic acid pinacol ester | |
CN108558916B (en) | Synthesis process of p-phenylbutoxy benzoic acid | |
CN107118168B (en) | A kind of copper catalyzes and synthesizes Trifluoromethyl-1, the method for 2,4- triazineon compounds | |
CN103773384B (en) | Liquid crystal compound containing cyclopentyl and pentafluoro-allyloxy and liquid crystal composition thereof | |
CN103756688A (en) | Pentafluoropropylene ether liquid crystal compound as well as preparation method and application thereof | |
CN105481738B (en) | A kind of method of the copper catalysis synthesis trifluoroethyl thioether of aromatic hydrocarbons 2,2,2 | |
CN104262127B (en) | Brush-type two fluorine monomer and synthetic method thereof | |
JP4894226B2 (en) | Method for producing fluorine-containing liquid crystal compound having hydroquinone skeleton | |
CN103694182B (en) | A kind of preparation method of quinoxaline compound | |
CN101503625B (en) | Preparation method of 1,2-diaryl ethine liquid crystal | |
CN103012047A (en) | Simple synthesis method of benzophenanthrene | |
CN108101755A (en) | A kind of method for preparing chiral 4- (2- propargyls) phenol compound | |
CN102675148A (en) | Preparation method of hydroxybenzyl cyanide | |
CN105541662A (en) | Solid phase synthesizing method of dihydronaphthalene compound | |
CN105399718A (en) | Solid phase synthesis method of 2H-benzopyran compounds | |
CN106674117A (en) | Selenium ionic liquid and preparation method thereof | |
CN104016869A (en) | 2,4,6-trinitro-1,3-di(2',4',6'-trinitro-3'-hydroxystyryl)benzene, synthetic method and applciation | |
CN103555346B (en) | 1, 3-dioxolane liquid crystal compound as well as preparation method and application thereof | |
CN104230719B (en) | A kind of method preparing substituted biphenyl | |
CN106866350A (en) | A kind of preparation method of the bromine fluorenes of high-purity 2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140507 Termination date: 20191016 |